Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XN2W
|
|||
| Drug Name |
Diaryl amine derivative 4
|
|||
| Synonyms |
PMID28092474-Compound-9
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histone deacetylase 3 (HDAC3) | Target Info | Inhibitor | [1] |
| Histone deacetylase 6 (HDAC6) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Histone deacetylase 3 (HDAC3) | Target's Patent Info | [1] | |
| Histone deacetylase 6 (HDAC6) | Target's Patent Info | [1] | ||
| KEGG Pathway | Thyroid hormone signaling pathway | |||
| Alcoholism | ||||
| Viral carcinogenesis | ||||
| Panther Pathway | Wnt signaling pathway | |||
| Pathway Interaction Database | Signaling events mediated by HDAC Class II | |||
| Signaling events mediated by HDAC Class I | ||||
| Retinoic acid receptors-mediated signaling | ||||
| Validated targets of C-MYC transcriptional repression | ||||
| Regulation of retinoblastoma protein | ||||
| Reactome | NOTCH1 Intracellular Domain Regulates Transcription | |||
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | ||||
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | ||||
| Assembly of the primary cilium | ||||
| WikiPathways | Ectoderm Differentiation | |||
| Neural Crest Differentiation | ||||
| Cell Cycle | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137).Expert Opin Ther Pat. 2017 Mar;27(3):229-236. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.